We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

VC-Backed Biotech Co. Leads 2 IPO Launches Totaling $139M

Law360 (July 10, 2018, 9:26 PM EDT) -- Venture capital-backed biotechnology firm Replimune Group Inc. launched an initial public offering estimated to raise about $101 million on Tuesday, joined by a Washington state community bank planning a $38 million IPO, adding to a packed lineup of deals scheduled to price next week.

Woburn, Massachusetts-based Replimune, represented by Morgan Lewis & Bockius LLP, told regulators it plans to offer 6.7 million shares priced between $14 and $16, raising $100.5 million if shares price at midpoint. Replimune was joined in the IPO pipeline by Coastal Financial...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.